Cyclone® iKure
Precision Against Cancer
- Therapy
- 211At
- Engineered for alpha therapy
Cyclone® iKure is purpose-built for routine, high-volume 211At production with consistent and reliable output.
- Compact, safe and easy to operate
Automated processes minimize operator exposure while fitting in standard size infrastructure.
- Energy
28.5 - 29.5 MeV
- Vault dimensions
6.5 x 6.5 x 3 m
- Target
Solid
- Production power
Up to 2 x 200 µAe / 2 x 100 µA particle
- Cyclotron dimensions
3 x 3 m
- Maximum reliability and performance
Backed by IBA’s four decades of cyclotron engineering, Cyclone® iKure delivers consistent, high-yield performance. Its operations are optimized for stability and reproducibility, ensuring precise activity levels and high purity in every production run.
- Compact and installation friendly
This state-of-the-art cyclotron is compact by design, allowing efficient use of space while maintaining full functionality for high-quality radiopharmaceutical production.
- Built to the highest industry standards
Manufactured under ISO 9001 standards, meeting the highest quality requirements and designed to be compliant with CE marking, Cyclone® iKure reflects IBA’s commitment to safety, durability and regulatory excellence.
- Ready when you are
IBA promises that your cyclotron is available when you are ready with your building.
Interested to learn more about the Cyclone® iKure?
Download product information
Find out everything you need to know about the Cyclone® iKure.
You don’t only have to take our word for it. Here is what others say about the Cyclone® iKure.
"Cyclone® iKure was designed to meet the growing demand for alpha-emitting radioisotopes, with a strong focus on Astatine-211. From the beginning, the objective was to engineer a system fully dedicated to alpha irradiation, optimized for performance and reliability. With Cyclone® iKure, IBA provides organizations with a robust solution to support radiopharmaceuticals production."